Chinook Therapeutics Inc. (KDNY) Chief Scientific Officer Owns Stock Worth $1168.0
Chinook Therapeutics Inc. (NASDAQ:KDNY) finished Thursday with an addition of $0.09 to close at $40.39, an upside of 0.22 percent. An average of 4,228,940 shares of common stock have been traded in the last five days. There was a gain of $0.10 in the past week, and it reached a new high 25 times over […]
Insider Activity Monitoring: Chinook Therapeutics Inc. (KDNY)
Chinook Therapeutics Inc. (NASDAQ:KDNY) saw an upside of 0.17% to close Monday at $40.35 after adding $0.07 on the day. The 5-day average trading volume is 5,125,600 shares of the company’s common stock. It has gained $40.47 in the past week and touched a new high 1 time within the past 5 days. An average […]
Chinook Therapeutics Inc. (KDNY) Price Targets: What Do They Mean?
As of Thursday close, Chinook Therapeutics Inc.’s (NASDAQ:KDNY) stock was up $0.1, moving up 0.25 percent to $40.29. The average number of shares traded per day over the past five days has been 4,777,180 shares. 3 times new highs have been achieved over the past 5 days, with a $1.36 gain in that time frame. […]
